Literature DB >> 17169347

Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

Rachel C Brown1, Andrew P Morris, Roger G O'Neil.   

Abstract

Understanding the molecular and biochemical mechanisms regulating the blood-brain barrier is aided by in vitro model systems. Many studies have used primary cultures of brain microvessel endothelial cells for this purpose. However, primary cultures limit the generation of material for molecular and biochemical assays since cells grow slowly, are prone to contamination by other neurovascular unit cells, and lose blood-brain barrier characteristics when passaged. To address these issues, immortalized cell lines have been generated. In these studies, we assessed the suitability of the immortalized mouse brain endothelial cell line, bEnd3, as a blood-brain barrier model. RT-PCR and immunofluorescence indicated expression of multiple tight junction proteins. bEnd3 cells formed barriers to radiolabeled sucrose, and responded like primary cultures to disrupting stimuli. Exposing cells to serum-free media on their basolateral side significantly decreased paracellular permeability; astrocyte-conditioned media did not enhance barrier properties. The serum-free media-induced decrease in permeability was correlated with an increase in claudin-5 and zonula occludens-1 immunofluorescence at cell-cell contracts. We conclude that bEnd3 cells are an attractive candidate as a model of the blood-brain barrier due to their rapid growth, maintenance of blood-brain barrier characteristics over repeated passages, formation of functional barriers and amenability to numerous molecular interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169347      PMCID: PMC1995120          DOI: 10.1016/j.brainres.2006.10.083

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  121 in total

1.  Effect of reduced flow on blood-brain barrier transport systems.

Authors:  S Hom; R D Egleton; J D Huber; T P Davis
Journal:  Brain Res       Date:  2001-01-26       Impact factor: 3.252

2.  Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.

Authors:  M Mukhtar; R J Pomerantz
Journal:  J Hum Virol       Date:  2000 Nov-Dec

3.  Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells.

Authors:  A Lippoldt; U Kniesel; S Liebner; H Kalbacher; T Kirsch; H Wolburg; H Haller
Journal:  Brain Res       Date:  2000-12-08       Impact factor: 3.252

4.  Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation.

Authors:  H Kubota; H Chiba; Y Takakuwa; M Osanai; H Tobioka; G Kohama; M Mori; N Sawada
Journal:  Exp Cell Res       Date:  2001-02-01       Impact factor: 3.905

Review 5.  Porcine Choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes.

Authors:  M Haselbach; J Wegener; S Decker; C Engelbertz; H J Galla
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

6.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

Authors:  P J Gaillard; L H Voorwinden; J L Nielsen; A Ivanov; R Atsumi; H Engman; C Ringbom; A G de Boer; D D Breimer
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

7.  Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells.

Authors:  S Fischer; M Wobben; J Kleinstück; D Renz; W Schaper
Journal:  Am J Physiol Cell Physiol       Date:  2000-10       Impact factor: 4.249

8.  Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.

Authors:  K A Witt; J D Huber; R D Egleton; T P Davis
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

9.  Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.

Authors:  H Asaba; K Hosoya; H Takanaga; S Ohtsuki; E Tamura; T Takizawa; T Terasaki
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

10.  Characteristics of endothelial cells derived from the blood-brain barrier and of astrocytes in culture.

Authors:  F A Ghazanfari; R R Stewart
Journal:  Brain Res       Date:  2001-01-26       Impact factor: 3.252

View more
  98 in total

1.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

2.  Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells.

Authors:  Masaru Yamamoto; Servio H Ramirez; Shinji Sato; Tomomi Kiyota; Ronald L Cerny; Kozo Kaibuchi; Yuri Persidsky; Tsuneya Ikezu
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

3.  Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.

Authors:  Chuanyi Zheng; Chunyang Ma; Enqi Bai; Kun Yang; Ruxiang Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Nerve growth factor-induced protection of brain capillary endothelial cells exposed to oxygen-glucose deprivation involves attenuation of Erk phosphorylation.

Authors:  Shimon Lecht; Hadar Arien-Zakay; Cezary Marcinkiewicz; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2009-12-10       Impact factor: 3.444

Review 5.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

6.  Absence of glial α-dystrobrevin causes abnormalities of the blood-brain barrier and progressive brain edema.

Authors:  Chun Fu Lien; Sarajo Kumar Mohanta; Malgorzata Frontczak-Baniewicz; Jerome D Swinny; Barbara Zablocka; Dariusz C Górecki
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

7.  Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia.

Authors:  A Kalani; P K Kamat; P Chaturvedi; S C Tyagi; N Tyagi
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

8.  3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes.

Authors:  Marco Campisi; Yoojin Shin; Tatsuya Osaki; Cynthia Hajal; Valeria Chiono; Roger D Kamm
Journal:  Biomaterials       Date:  2018-07-12       Impact factor: 12.479

9.  Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.

Authors:  Anuradha Kalani; Pradip K Kamat; Anastasia Familtseva; Pankaj Chaturvedi; Nino Muradashvili; Nithya Narayanan; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

10.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor.

Authors:  Jacquelyn A Brown; Virginia Pensabene; Dmitry A Markov; Vanessa Allwardt; M Diana Neely; Mingjian Shi; Clayton M Britt; Orlando S Hoilett; Qing Yang; Bryson M Brewer; Philip C Samson; Lisa J McCawley; James M May; Donna J Webb; Deyu Li; Aaron B Bowman; Ronald S Reiserer; John P Wikswo
Journal:  Biomicrofluidics       Date:  2015-10-26       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.